BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28411145)

  • 21. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
    Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER
    Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Chung SH; Woldenberg N; Roth AR; Masamed R; Conlon W; Cohen JG; Joines MM; Patel MK
    Radiographics; 2020; 40(2):306-325. PubMed ID: 32031911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
    Kalkan E; Waguespack SG
    Front Horm Res; 2013; 41():166-81. PubMed ID: 23652677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
    Lynch HT; Casey MJ; Snyder CL; Bewtra C; Lynch JF; Butts M; Godwin AK
    Mol Oncol; 2009 Apr; 3(2):97-137. PubMed ID: 19383374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary cancer syndromes as model systems for chemopreventive agent development.
    Walcott FL; Patel J; Lubet R; Rodriguez L; Calzone KA
    Semin Oncol; 2016 Feb; 43(1):134-145. PubMed ID: 26970132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary cancer syndromes.
    Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
    J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent advances and future development on Lynch syndrome-associated endometrial cancer].
    Ning Y; Wang Y; Wang YY; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913
    [No Abstract]   [Full Text] [Related]  

  • 34. Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
    Pokharel HP; Hacker NF; Andrews L
    Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):633-638. PubMed ID: 27530527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification of Lynch syndrome in Congolese colorectal cancer patients.
    Poaty H; Aba Gandzion C; Soubeyran I; Gassaye D; Peko JF; Nkoua Bon JB; Gombé Mbalawa C
    Bull Cancer; 2017 Oct; 104(10):831-839. PubMed ID: 28988047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.
    Castro E; Goh CL; Eeles RA
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retesting of women who are negative for a
    Lerner-Ellis J; Sopik V; Wong A; Lázaro C; Narod SA; Charames GS
    J Med Genet; 2020 Jun; 57(6):380-384. PubMed ID: 31784482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics of inherited predispositions to colorectal polyps: a quick guide for clinicians.
    Ricci MT; Salemme M; Villanacci V; Varesco L
    Colorectal Dis; 2015 Jan; 17 Suppl 1():3-9. PubMed ID: 25511854
    [No Abstract]   [Full Text] [Related]  

  • 40. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
    Mitchell G; Schrader KA
    Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.